Zambiri ― Chichewa

Urticaria nthawi zambiri amakhala ndi zoyabwa zokwezeka kwambiri. Nthawi zina amatsagana ndi kutupa kwa minofu yapansi. Chithandizo makamaka chimaphatikizapo kupewa zinthu zomwe zingayambitse, ngati zikudziwika. Mankhwala a mzere woyamba amaphatikizapo antihistamines atsopano, omwe amatha kusinthidwa kukhala apamwamba ngati akufunikira. Mankhwala ena monga antihistamines akale, H2 blockers, leukotriene receptor antagonists, antihistamines amphamvu, ndi maphunziro afupiafupi a corticosteroids akhoza kuwonjezeredwa ngati chithandizo chowonjezera. Ngati urticaria ikupitilirabe ngakhale izi zimachitika, odwala amatha kutumizidwa kwa akatswiri kuti akalandire chithandizo chowonjezera monga omalizumab kapena cyclosporine.
Urticaria commonly presents with intensely itchy raised welts. It is sometimes accompanied by swelling of the underlying tissues. Treatment primarily involves avoiding triggers, if known. First-line medication includes newer antihistamines, which can be adjusted to higher doses if needed. Other medications like older antihistamines, H2 blockers, leukotriene receptor antagonists, stronger antihistamines, and short courses of corticosteroids can be added as extra support. In cases where urticaria persists despite these measures, patients might be referred to specialists for additional therapies such as omalizumab or cyclosporine.

Ndemangayi ikuwonetsa malangizo aposachedwa ochizira urticaria ndikupereka kumvetsetsa kwatsopano zomwe zimayambitsa.
This review outlines the latest guidelines for treating urticaria and offers new understandings of its causes.

Second-generation H1-antihistamines (e.g., cetirizine, loratadine, fexofenadine), Omalizumab, Ciclosporin, and short courses only of systemic corticosteroids